---
figid: PMC9535628__or-48-05-08410-g05
pmcid: PMC9535628
image_filename: or-48-05-08410-g05.jpg
figure_link: /pmc/articles/PMC9535628/figure/f6-or-48-05-08410/
number: Figure 6
figure_title: ''
caption: Ten candidate circRNAs between ORR patients and non-ORR patients. Comparisons
  of (A) circ_0026652, (B) circ_0068708, (C) circ_0088128, (D) circ_0001566, (E) circ_0005327,
  (F) circ_0031113, (G) circ_0083587, (H) circ_0005552, (I) circ_0007171 and (J) circ_0007521
  expression levels between ORR patients (n=43) and non-ORR (n=17) patients. CircRNA/circ,
  circular RNA; ORR, objective response rate.
article_title: Dysregulated circular RNAs are closely linked to multiple myeloma prognosis,
  with circ_0026652 predicting bortezomib-based treatment response and survival via
  the microRNA-608-mediated Wnt/Î²-catenin pathway.
citation: Lu Li, et al. Oncol Rep. 2022 Nov;48(5):195.
year: '2022'

doi: 10.3892/or.2022.8410
journal_title: Oncology Reports
journal_nlm_ta: Oncol Rep
publisher_name: D.A. Spandidos

keywords:
- multiple myeloma
- circular RNA profiles
- circular RNA 0026652
- prognosis
- chemosensitivity to bortezomib

---
